Company: LDDD
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001213900-25-042963
Chunk: 241

Company: Longduoduo Co Ltd
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 8
Chunk 241
---
  
     (18,153) 
     (47)%
  
    Gross Profit 
     757,276  
     1,751,487  
     (994,211) 
     (57)%
  
    Total operating expenses 
     876,095  
     1,032,623  
     (156,528) 
     (15)%
  
    Loss from operations 
     (118,819) 
     718,864  
     (837,683) 
     (117)%
  
    Other income (expense), net 
     2,583  
     (9,603) 
     12,186  
     (127)%
  
    Income (loss) before income taxes 
     (116,236) 
     709,261  
     (825,497) 
     (116)%
  
    Income tax 
     84  
     191,292  
     (191,208) 
     (100)%
  
    Net income (loss) 
    $(116,320) 
    $517,969  
    $(634,289) 
     (122)%

2

During the three months ended March 31, 2025,
our total revenue was $777,720, of which $28,724 was attributable to the sale of healthcare services, primarily derived from sales of
“Immunological Ozonated Autohemotherapy”, “Meridian-regulating and Consciousness-restoring Iatrotechnics”, “Assay”,
“PRP” and other healthcare services. The remaining $748,996 of revenue was attributable to commissions earned by the Company
from its service as sales agent for Inner Mongolia Honghai Health Management Co., Ltd. (“Honghai”). In June of 2023, the Company
began to engage in the sales agent business and focused on the sales of preventive healthcare solutions administered by Honghai, with
whom we have a Sales Agency Agreement. As of March 31, 2025, we operate through seven entities: Longduoduo Health Technology, Tianju,
Qingguo, Rongbin, Chengheng, Julong and Yihua which are established in Ordos, Ulanqab, Huhhot, Baotou, Ordos and Beijing, respectively,
which include four of the largest